Pletal for the Treatment of Intermittent Claudication

Brand Name: Pletal Active Ingredient: cilostazol Approved uses: the reduction of symptoms of intermittent claudication, as indicated by an increase in walking distance Dosage Form(s): Tablets (50 mg and 100 mg) Company Name: Otsuka America Pharmaceutical, Inc. Treatment options for intermittent claudication – a severe pain, aching or cramping in the legs that occurs with walking – include exercise regimens, surgery, and pharmacological therapy. Until recently the only medication available for the treatment of intermittent claudication has been Trental(R) (pentoxifylline).

Novantrone: Managing Multiple Sclerosis

Immunex submitted an NDA – New Drug Application – for Novantrone (mitoxantrone) on June 7, 1999 for a new multiple sclerosis (MS) indication, and it was granted “priority review” status on July 17, 1999. Novantrone was initially indicated for the treatment of patients with pain due to advanced hormone-refractory prostate cancer. It can also be used as a component of combination therapy for acute nonlymphocytic leukemia in adults.

Sonata: the Treatment of Insomnia

Brand Name: Sonata Active Ingredient: zaleplon Indication: Treatment of short-term insomnia Company Name: Wyeth-Ayerst Laboratories, Inc. According to the National Sleep Foundation, insomnia affects nearly 83 million Americans; however, many people avoid sleep aids for fear of next-day drowsiness.

Exelon: Drug for Alzheimer’s Disease

Some 4 million Americans are afflicted with Alzheimer’s disease, a number that is expected to grow as the population ages. Tacrine (Cognex) and donepezil (Aricept) are prescription drugs currently available to treat symptoms or slow progression of the disease.

Malarone for Prevention and Treatment of Malaria

Brand Name: Malarone Active Ingredient: atovaquone and proguanil hydrochloride Indication: Treatment and prevention of P. falciparum malarial infection in adults and children Company Name: Glaxo Wellcome Inc. The antimalarial drug atovaquone was developed in the 1980s and was shown to be effective when used alone, but a recurrence of malaria was observed in some patients over time.

Actonel: Drug for Osteoporosis

Brand Name Drug: Actonel Active Ingredient Drug: risedronate sodium Indication: Treatment and prevention of postmenopausal osteoporosis and glucocorticoid-induced osteoporosis (also approved for Paget’s disease of the bone in March 1998). Actonel (risedronate disodium) was approved in 1998 for the treatment of Paget’s disease. Now the drug, manufactured by Procter & Gamble and co-marketed with Aventis Pharmaceuticals, has received approval from the FDA (in April 2000) for the treatment and prevention of postmenopausal osteoporosis (PMO) and glucocorticoid-induced osteoporosis (GIO).

Tamiflu: A Targeted Approach for Treating Influenza

Brand Name: Tamiflu Active Ingredient: oseltamivir phosphate Indication: Treatment of influenza A and B Company Name: Hoffmann-La Roche Inc. and Gilead Sciences, Inc. Some 40 million Americans develop the flu every year, putting about 300,000 in the hospital.

Boniva Drug for Treatment of Osteoporosis

Osteoporosis affects over 10 million Americans, and it is estimated that an additional 15 to 20 million people are at risk for developing the disease. The majority (80%) of those afflicted with osteoporosis are female. The onset of osteoporosis occurs as early as age 40 and it is responsible for bone fractures in nearly half of all women over age 50.

Drug Zeldox for Treatment of Schizophrenia

Schizophrenia afflicts some one percent of the world’s population and requires lifelong treatment. In the US alone, the illness costs the country more than $104 billion in hospital costs, medications, health-care services, and lost productivity.

Ansaid Tablets: An anti-inflammatory analgesic agent

Ansaid (flurbiprofen) is indicated for the relief of signs and symptoms of rheumatoid arthritis, osteoarthritis and ankylosing spondylitis. Ansaid is also indicated for the relief of pain associated with dysmenorrhoea.

Zaditor: Relief of Ocular Itching

Following a priority review, Zaditor (ketotifen) was approved by the FDA on July 2, 1999. The priority review was granted because, as an antihistamine for ocular itching, Zaditor is in a different class from other currently approved ocular itching drugs.

Agenerase for the Management of HIV-1 Infection

Agenerase (amprenavir) – the first new protease inhibitor in two years – is the fifth protease inhibitor to reach the US market. Agenerase, developed by Vertex Pharmaceuticals, Inc. and licensed to Glaxo Wellcome, was approved by the FDA in April 1999. Unlike most other protease inhibitors that have to be taken three times daily, Agenerase has a long half-life and can be given twice daily.

Penlac: Drug for Topical Treatment of Nail Fungus

Millions of Americans, particularly those between the ages of 40 and 60, suffer from onchomycosis, a persistent fungal infection of the nails. It occurs when dermatophyte fungi, usually Trichophyton rubrum, invade the nail bed. Men and the elderly are afflicted most often, although the infection can strike all ages and women as well.

Novantrone For Multiple Sclerosis Symptoms

Brand Name: Novantrone Active Ingredient: mitoxantrone Indication: Treatment of patients with multiple sclerosis Company Name: Immunex Corporation Availability: FDA approval of Novantrone for multiple sclerosis on January 31, 2000. Novantrone is already marketed for the treatment patients with pain related to advanced hormone-refractory prostate cancer (when used with corticosteroids) and as part of initial combination treatment of acute nonlymphocytic leukemia in adults.

Mobic Tablets for Treatment of Osteoarthritis

As the population ages, the need for effective pain relief from osteoarthritis – which currently affects 80% of Americans over age 65 — is expected to increase. Millions of people are still searching for an effective treatment they can tolerate.

Innohep, Once-Daily Treatment for Deep Vein Thrombosis

Blood clots in the veins, especially in the legs, are a common and very serious problem that affects some 5 million Americans each year. Such deep vein thrombosis (DVT) can lead to pulmonary embolism (a blood clot that travels to the lungs), which develops in about 500,000 people each year and is fatal in some 50,000 of them.

Relpax for Migraine

During a migraine headache attack, brain activity changes induce inflammation of cerebral blood vessels and nerves. Attacks may be triggered by alcohol, certain foods, too much or too little sleep, menstruation, emotional stress, or environmental factors.

Chirocaine for local or regional anesthesia

Brand Name: Chirocaine Active Ingredient: levobupivacaine Indication: Chirocaine induces local or regional anesthesia for surgery and obstetrics. It is also indicated for post-operative pain management. Company Name: Purdue Pharma L.

Cenestin: Treatment of Vasomotor Symptoms Associated with Menopause

Brand Name: Cenestin Active Ingredient: synthetic conjugated estrogens, A Indication: Treatment of moderate to severe vasomotor symptoms associated with menopause. Company Name: Duramed Pharmaceuticals, Inc. Cenestin is a blend of nine synthetic conjugated estrogens derived from plant sources that provides an alternative to animal-derived estrogens.

Celebrex: It’s Not Just for Arthritis Anymore

Familial adenomatous polyposis (FAP) is a hereditary disease characterized by the development of hundreds and even thousands of potentially precancerous adenomatous polyps in the colon and rectum, which typically first appear in adolescence and early adulthood. Left untreated, virtually all patients with FAP develop colorectal cancer by age 40 or 50. The mainstay of care for these patients has been endoscopic surveillance and surgery when necessary.